Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues
- PMID: 1704191
- PMCID: PMC1886196
Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues
Abstract
Inducible cell adhesion molecule 110 (INCAM-110), is a 110-kd adhesion receptor for lymphocytes and monocytes identified on cytokine-activated endothelium. Using immunoperoxidase techniques, little or no INCAM-110 was detected on endothelium in normal human tissues. In contrast, INCAM-110 was expressed in postcapillary venules in a variety of active inflammatory processes. In acute appendicitis, INCAM-110 was found coincident with strong expression of endothelial leukocyte adhesion molecule 1 (ELAM-1), a cytokine-inducible molecule that functions in neutrophil adhesion. However, in certain chronic inflammatory processes (eg, sarcoidosis), INCAM-110 was observed without simultaneous ELAM-1 expression. Anti-INCAM-110 antibody E1/6 also marked several extravascular cell types, including lymphoid dendritic cells, some tissue macrophages, synovial lining cells, and reactive mesothelial cells. These data suggest a role for endothelial INCAM-110 in the pathophysiology of both acute and chronic inflammatory reactions. Furthermore INCAM-110 may function as an adhesion molecule for mononuclear leukocytes in a variety of extravascular sites.
Similar articles
-
Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism.J Exp Med. 1990 Apr 1;171(4):1369-74. doi: 10.1084/jem.171.4.1369. J Exp Med. 1990. PMID: 1691264 Free PMC article.
-
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues.Am J Pathol. 1992 Dec;141(6):1397-408. Am J Pathol. 1992. PMID: 1281620 Free PMC article.
-
Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1.Cell Regul. 1991 May;2(5):347-55. doi: 10.1091/mbc.2.5.347. Cell Regul. 1991. PMID: 1716464 Free PMC article.
-
Endothelial-leukocyte adhesion molecules.Annu Rev Immunol. 1993;11:767-804. doi: 10.1146/annurev.iy.11.040193.004003. Annu Rev Immunol. 1993. PMID: 8476577 Review.
-
Endothelial-leukocyte adhesive interactions in inflammatory diseases.Eur Heart J. 1993 Dec;14 Suppl K:72-7. Eur Heart J. 1993. PMID: 7510638 Review.
Cited by
-
Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma.Am J Pathol. 1993 Dec;143(6):1551-9. Am J Pathol. 1993. PMID: 7504883 Free PMC article.
-
Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands.J Exp Med. 1995 Jan 1;181(1):411-5. doi: 10.1084/jem.181.1.411. J Exp Med. 1995. PMID: 7528776 Free PMC article.
-
Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells.Am J Pathol. 1995 Feb;146(2):409-18. Am J Pathol. 1995. PMID: 7531954 Free PMC article.
-
Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins.J Clin Invest. 1997 Oct 1;100(7):1725-33. doi: 10.1172/JCI119697. J Clin Invest. 1997. PMID: 9312170 Free PMC article.
-
Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants.Ann Rheum Dis. 1995 Mar;54(3):201-8. doi: 10.1136/ard.54.3.201. Ann Rheum Dis. 1995. PMID: 7538286 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources